View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 20, 2021

Coronavirus company news summary – Abbott begins delivering BinaxNOW Covid-19 Ag self-test to retailers – Therma Bright receives CE approval for Covid-19 rapid antigen saliva test

By Chloe Kent

Abbott has started delivering its BinaxNOW Covid-19 Ag Self-Test to retailers across the US. The test is expected to be available to customers on online platforms and at some retail stores such as CVS Pharmacy, Walmart, and Walgreens without a prescription. The self-test will be more broadly available in the upcoming two weeks. The company manufactures millions of self-tests per month and is looking at scaling capacity based on demand.

Therma Bright has received CE mark approval for its AcuVid Covid-19 rapid antigen saliva test. The company has also secured a conditional purchase order for 100,000 units through McWilliams Collective, a new global distribution partner. The order is secured for a large European client, on conditions that the company provides the initial test data which demonstrates 86%+ specificity and 100% sensitivity, and that the production levels are reached and delivered in June 2021.

RICOVR Healthcare has raised $1.5m to fund the commercialisation of its point-of-care testing device for both tetrahydrocannabinol (THC), a psychoactive constituent of cannabis, and Covid-19 disease. The company’s biosensor platform allows a small saliva sample to deliver results within just five minutes. The funding is expected to support the go-to-market goals for the XALIVA platform.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU